Page 1Apple_logo_blackPage 1Page 1Page 1TrianglePage 1close iconPage 1Page 1Fill 1Group 3!Fill 1Icons / icon-checkicon-cvvCVVCVVicon-down-arrowicon-upicons/icon-menu-v2Icons / icon-multiplyicon-plusIcons / icon-quoteicon-up-arrowicon-upFill 6logo/logo-bluelogo-smalllogoPage 1Page 1Page 1GroupPage 1GroupFill 1Triangle 1plus-buttonPage 1Page 1Page 1Page 1Fill 4

Bloomlife hits the news.

Coverage for our innovative solutions and mission to solve the biggest challenges in prenatal care.

With Bloomlife, women are able to better interpret what’s going on in their bodies, from gas to early contractions to labor.

Now that ECG monitors have become comfortably wearable for adults, Bloomlife researchers are preparing to take the technology to the next level.

Bloomlife's pregnancy contraction monitoring wearable informs and empowers expecting moms.

A trustworthy system for women to better understand their pregnancy and their body.

Press Releases

Executive Bios

Eric Dy, Co-Founder & CEO

Eric brings a unique perspective on the needs, opportunities, and challenges in emerging healthcare technologies and delivery models informed by multi-disciplinary expertise gained through business development in consumer and medical markets. Prior to co-founding Bloomlife, Eric served as senior business development manager at IMEC leading sales and partnership activities in North America. In his 3 years leading business development, Eric established development and licensing partnerships covering next gen sequencing, remote patient monitoring, hyperspectral imaging, and mixed signal chip design. Eric earned his BSc in Bioengineering from Cornell and his MSc and PhD in Biomedical Engineering from UCLA. He is (co)-author of 14 scientific publication and 9 patents.

Since founding in 2014, Eric and the Bloomlife team have received various awards including MedTech Innovator Award, Parent Tested Parent Approved, CES Innovation Award, and National Parenting Product Awards. Additionally Eric has spoken at the White House Precision Public Health Summit and won Richard Branson’s Extreme Tech Challenge Award in 2016.

Julien Penders, Co-Founder & COO

Building upon 13 years of experience heading health and wellness product development, Julien leads technology, product development and operations. Julien brings a unique experience gained while pioneering the field of digital health technologies at IMEC, where he started, grew and directed a multidisciplinary international team. Julien’s wife first pregnancy was a source of inspiration for the origins of Bloomlife.

Prior to starting Bloomlife, Julien was Program Director at IMEC where he built and led a team of 35 engineers and scientists developing remote patient monitoring and digital health solutions. He has led wearable health projects for market leaders in both the medical and consumer spaces, covering all aspects of system design from Integrated Circuits to algorithms to system and clinical validation. A few notable examples include the development of a cardiac monitoring patch that was successfully taken to FDA, the development of low-power headsets for brain monitoring, and the development of the reference sensor module for Samsung’s Simband platform announced in 2014.

Julien has (co-) authored over 60 papers and 9 patents in the field of wearable technologies and connected health. He has been a keynote or invited speakers at multiple public events and conferences, including TEDx and the Creativity
World Forum. He was general co-chair for the Wireless Health conference in 2013 and 2014, and general co-chair for the International Biomedical and Health Informatics conference in 2018. He serves on the IEEE Technical Committee on Biomedical and Health Informatics and sits on the Program Committees for several international conferences. Julien was a 2004/2005 fellow of the Belgian American Educational Foundation. He holds a M.Sc. degree in Engineering Physics from University of Liege, Belgium (2004), and a M.Sc. degree in Biomedical Engineering from Boston
University, MA (2006).

Get in touch!

For all press inquiries, please contact: